Across TCGA pan-cancer cohorts, NDUFA5P12 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NDUFA5P12’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where NDUFA5P12 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFA5P12 is over-expressed in tumor.
UCEC and LIHC are the cancer types where NDUFA5P12 tumor–normal differential expression is most reproducible.